Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2005
08/10/2005CN1653062A (imidazol-1-yl-methyl)-pyridazine as NMDA receptor blocker
08/10/2005CN1653059A Macrocyclic compounds useful as pharmaceuticals
08/10/2005CN1653057A Manufacture of ascorbic acid esters
08/10/2005CN1653055A Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same
08/10/2005CN1653054A Benzoxazine derivatives as 5-HT6 modulators and uses thereof
08/10/2005CN1653053A Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
08/10/2005CN1653052A Novel imidazole compounds, method for preparing same and use thereof as medicines
08/10/2005CN1653051A Substituted anthranilamides for controlling invertebrate pests
08/10/2005CN1653050A Opioid and opioid-like compounds and uses thereof
08/10/2005CN1653049A Pesticidal pyridinecarboxamide derivatives
08/10/2005CN1653048A Pyridine carboxamide derivatives and their use as pesticides
08/10/2005CN1653047A Monocyclic aroylpyridinones as antiinflammatory agents
08/10/2005CN1653045A 8-azaprostaglandin analogs as agents for lowering intraocular pressure
08/10/2005CN1653044A Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
08/10/2005CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
08/10/2005CN1653040A HIF hydroxylase inhibitors
08/10/2005CN1653039A Amidoacetonitrile compounds and their use as pesticides
08/10/2005CN1653037A Substituted tetracycline compounds
08/10/2005CN1653036A Amino acids with affinity for the alpha-2-delta-protein
08/10/2005CN1653025A NK1 antagonists
08/10/2005CN1652845A Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
08/10/2005CN1652844A Combination of a CDK inhibitor and 5-FU for the treatment of cancer
08/10/2005CN1652843A Methods for the treatment of respiratory diseases and conditions using a selective iNOS inhibitor
08/10/2005CN1652842A 3'- (2z)- 1-(3, 4-dimethylphenyl)-1, 5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy- 1, 1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
08/10/2005CN1652814A Induction of antigen specific immunologic tolerance
08/10/2005CN1652812A Combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
08/10/2005CN1652811A A combination product comprising melagatran and an anti-arrhythmic oxabispidenes
08/10/2005CN1652808A Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic
08/10/2005CN1652807A Formulations useful in the treatment of male and female impotence
08/10/2005CN1652806A Formulations useful in the treatment of male and female impotence
08/10/2005CN1652803A Medicine for prevention of and treatment for amyloidosis
08/10/2005CN1652801A Mineral absorption promoter
08/10/2005CN1652800A Remedies for lung cancer
08/10/2005CN1652799A Sulfatase inhibiting progestogen-only contraceptive regimens
08/10/2005CN1652798A Continuous sulfatase inhibiting progestogen hormone replacement therapy
08/10/2005CN1652797A Sulfatase inhibiting continuous progestogen contraceptive regimens
08/10/2005CN1652796A Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
08/10/2005CN1652795A Compositions and methods for treating emphysema
08/10/2005CN1652794A Neuroprotective spirostenol pharmaceutical compositions
08/10/2005CN1652793A Androgen pharmaceutical composition and method for treating depression
08/10/2005CN1652792A N3 alkylated benzimidazole derivatives as MEK inhibitors
08/10/2005CN1652791A Synergistic enhancement of cognitive ability
08/10/2005CN1652790A Novel crystalline forms of the anti-cancer compound ZD1839
08/10/2005CN1652789A Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins
08/10/2005CN1652788A Method of treating diabetes
08/10/2005CN1652787A Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
08/10/2005CN1652786A Fluorinated 4-azasteroid derivatives as androgen receptor modulators
08/10/2005CN1652785A Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
08/10/2005CN1652784A Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
08/10/2005CN1652783A Compositions and method for treating infection in cattle and swine
08/10/2005CN1652782A Nicotinamide derivatives useful as PDE4 inhibitors
08/10/2005CN1652781A Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin
08/10/2005CN1652780A Diaminothiazoles used as CDK4 inhibitors
08/10/2005CN1652779A Treatment of chemokine mediated diseases
08/10/2005CN1652778A Method for treating obesity
08/10/2005CN1652777A Combination of organic compounds
08/10/2005CN1652776A N3 alkylated benzimidazole derivatives as MEK inhibitors
08/10/2005CN1652775A Peptide deformylase inhibitors
08/10/2005CN1652774A Use of valsartan or its metabolite to inhibit platelet aggregation
08/10/2005CN1652773A Substantially pure solid form of the enol tautomer of 3-indolylpyruvic acid for use in the treatment of central nervous system disturbances
08/10/2005CN1652772A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-dione: methods of using and compositions thereof
08/10/2005CN1652771A Annelated pyrrole compounds as proton pump inhibitors for treating ulcer
08/10/2005CN1652770A Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
08/10/2005CN1652769A Phosphate prodrugs of fluorooxindoles
08/10/2005CN1652768A 5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replaceme
08/10/2005CN1652767A Adduct of topiramate and tramadol hydrochloride and uses thereof
08/10/2005CN1652766A Topical formulations of resorcinols and cannibinoids and methods of use
08/10/2005CN1652765A Antitumor agent containing cyclic polylactic acid
08/10/2005CN1652764A TGF-alpha expression inhibitors
08/10/2005CN1652763A Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
08/10/2005CN1652762A Anti-rhinovirus active agents
08/10/2005CN1652761A Preventive or therapeutic agent for kidney disease
08/10/2005CN1652760A Tamsulosin tablets
08/10/2005CN1652759A Small molecule entry inhibitors
08/10/2005CN1652758A Methods of treating gastrointestinal and genitourinary pain disorders using vinlafaxin and derivatives
08/10/2005CN1652757A Use of EDG receptor binding agents in cancer
08/10/2005CN1652756A Matrix type patch containing bronchodilators
08/10/2005CN1652755A Oral suspension of active principle microcapsules
08/10/2005CN1652754A Tasted masked veterinary solid compositions
08/10/2005CN1652753A Clarithromycin formulations having improved bioavailability
08/10/2005CN1652752A Naltrexone hydrochloride compositions
08/10/2005CN1652751A A method to improve surface properties of pharmaceutical tablets
08/10/2005CN1652750A Taste masked compositions of erythromycin A and derivatives thereof
08/10/2005CN1652743A Hair growth tonic
08/10/2005CN1652701A Acidic compositions comprising protein and fiber and processes of their preparation
08/10/2005CN1652698A Method and dietary composition for improving lipid digestibility
08/10/2005CN1652697A Method and dietary composition for improving fat digestibility
08/10/2005CN1652696A Method of improving absorption of vitamin E by a pet animal
08/10/2005CN1652695A Method of improving growth performance of animal
08/10/2005CN1652687A Choline-silicic acid complex with osmolytes and divalent trace elements
08/10/2005CN1651577A Conditionally replicating viral vectors and their use
08/10/2005CN1651470A Low molecular weight heparin triethanolamine salt usable as local delivery antithrombotic treating agent, preparing process and use thereof
08/10/2005CN1651469A Hijiki polysaccharide SFP-I, its separation purification method and application
08/10/2005CN1651466A Sulphatization derivative of polysaccharide, its preparation method and use
08/10/2005CN1651465A Glycosyl modified dietary fiber, its preparation method and application
08/10/2005CN1651455A Pseudo portulaca oleracea saponin compound, total sapon in and its application in medicine
08/10/2005CN1651453A Japanese polygala saponin kind compound and aglucon, total saponin and total aglucon and its application in medicine
08/10/2005CN1651452A Panaxcoside secondary glucoside fatty acid ester compound, its preparation method and medicinal composition using said compound as active ingredient
08/10/2005CN1651451A 20(SO)ortho ginseng diol derivative, medicinal composition containing them and its application
08/10/2005CN1651450A Small interference RNA molecule (SiRNA) capable of effectively killing and wounding tumour cell pointed at PLK1 mRNA, its mixture and use
1 ... 4586 4587 4588 4589 4590 4591 4592 4593 4594 4595 4596 4597 4598 4599 4600 4601 4602 4603 4604 4605 4606 ... 7860